Physician profile
Michael B Erwin
NPI 1710907878
$4,207.84
in general payments reported to CMS, 2019-2025
44 companies · $888 in 2025
The $888 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $163 · 2021: $678 · 2022: $422 · 2023: $458 · 2024: $917 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $412.57 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.59 | 2019-2025 | Jardiance |
| Amgen INC. | $302.32 | 2019-2024 | Repatha |
| Abiomed | $275.27 | 2019-2025 | Impella |
| Abbott Laboratories | $255.90 | 2021-2024 | Dragonfly Opstar, Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $228.40 | 2019-2024 | Xarelto |
| Pfizer INC. | $214.48 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.45 | 2019-2025 | Lifevest |
| Philips North America LLC | $193.47 | 2019-2025 | Holter, (5050) Extended Holter, (Ck4) Mcot |
| Boston Scientific Corporation | $184.39 | 2019-2024 | Watchman Flx |
| Novo Nordisk INC | $147.10 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Cardiva Medical, INC. | $142.92 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Scpharmaceuticals INC. | $123.65 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $97.04 | 2022-2023 | Optimizer |
| Atricure, INC. | $96.40 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Erwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.